Firefly Neuroscience (AIFF) COO gains 44,872 vested shares in stock award

Rhea-AI Filing Summary

FIREFLY NEUROSCIENCE, INC. director and President & COO David DeCaprio reported acquiring 44,872 shares of Common Stock, received as a grant or award at a price of $0.00 per share. After this vesting event, he directly owns 77,866 Common Stock shares.

The shares relate to restricted stock units originally granted on April 18, 2025 for 263,952 shares under the 2024 Long-Term Incentive Plan. On March 10, 2026, the Compensation Committee determined the performance conditions were met, triggering vesting of these 44,872 shares as part of that larger award.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DeCaprio David

(Last) (First) (Middle)

1100 MILITARY ROAD

(Street)

KENMORE NY 14217

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
FIREFLY NEUROSCIENCE, INC. [ AIFF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and COO

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		A(1)		44,872	A	$0.00	77,866	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On April 18, 2025, the Reporting Person was granted restricted stock units under the Issuer's 2024 Long-Term Incentive Plan for 263,952 shares of Common Stock. On March 10, 2026, the Compensation Committee of the board of directors of the Issuer determined that the performance conditions had been met for the vesting of 44,872 of these shares.

	/s/ David DeCaprio	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did FIREFLY NEUROSCIENCE (AIFF) report for David DeCaprio?

FIREFLY NEUROSCIENCE reported that President and COO David DeCaprio acquired 44,872 shares of Common Stock. These shares were received as a grant or award, not purchased in the open market, and resulted from vesting of previously granted restricted stock units.

How many FIREFLY NEUROSCIENCE (AIFF) shares does David DeCaprio hold after this Form 4?

After this transaction, David DeCaprio directly holds 77,866 shares of FIREFLY NEUROSCIENCE Common Stock. This reflects the addition of 44,872 vested shares from a prior restricted stock unit grant once performance conditions were confirmed as achieved.

What was the price per share for David DeCaprio’s FIREFLY NEUROSCIENCE (AIFF) award?

The award to David DeCaprio was recorded at a price of $0.00 per share. This indicates the shares were granted as compensation, tied to vesting conditions, rather than bought for cash in an open-market transaction or private purchase.

What performance-based award underpins David DeCaprio’s latest FIREFLY NEUROSCIENCE (AIFF) shares?

The vested shares come from a restricted stock unit grant made on April 18, 2025 for 263,952 shares under the 2024 Long-Term Incentive Plan. On March 10, 2026, the Compensation Committee confirmed performance conditions for 44,872 of those units had been satisfied.

Is David DeCaprio’s FIREFLY NEUROSCIENCE (AIFF) Form 4 an open-market buy or a compensation grant?

The Form 4 reflects a compensation-related grant, not an open-market purchase. The 44,872 shares were acquired at $0.00 per share when performance-based restricted stock units vested after the Compensation Committee determined conditions had been met.